Weight Loss as a Predictor of Survival and Disease Progression in HIV Infection
- 1 May 1998
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 18 (1) , 80-85
- https://doi.org/10.1097/00042560-199805010-00012
Abstract
Severe weight loss in HIV is associated with decreased length of survival. It is unclear whether mild weight loss is associated with an increased risk of death or opportunistic complications of HIV. Participants in four interventional studies (n = 2382) conducted by a community-based clinical trials network were evaluated for percentage change in weight during their first 4 months in the study. Proportional hazards models were performed for the occurrence of opportunistic complications and death subsequent to the 4-month visit. The relative risk of death and opportunistic complications for those with 5% to 10% weight loss over 4 months was 2.22 (p < .001) and 1.89 (p < .001), respectively, and 1.26 (p < .01) and 1.19 (p < .01) among those who lost 0% to 5% of their body weight, respectively, when compared with those with no weight loss. Among those who lost 5% to 10% of their body weight, the relative risk of individual opportunistic complications increased significantly, including Pneumocystis carinii pneumonia (PCP) (1.61; p < .01), cytomegalovirus (CMV) (2.33; p < .001), and Mycobacterium avium complex (MAC) (1.81; p < .01). As little as 5%t weight loss over a 4-month period is associated with increased risk of death and opportunistic complications in HIV. A weight loss of 5% to 10% is also associated with an increased risk of individual opportunistic complications.Keywords
This publication has 13 references indexed in Scilit:
- Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Weight Loss Prior to Clinical AIDS as a Predictor of SurvivalJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1994
- Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized TrialThe Journal of Infectious Diseases, 1994
- Changes in the Mix of AIDS-Defining ConditionsNew England Journal of Medicine, 1993
- Clinical Manifestations of AIDS in the Era of Pneumocystis ProphylaxisNew England Journal of Medicine, 1993
- Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndromeThe American Journal of Clinical Nutrition, 1993
- Clinical Factors Associated with Weight Loss Related to Infection with Human Immunodeficiency Virus Type 1 in the Multicenter AIDS Cohort StudyAmerican Journal of Epidemiology, 1993
- HIV wasting syndrome in the United StatesAIDS, 1993
- Effect of Home Total Parenteral Nutrition on Body Composition in Patients with Acquired Immunodeficiency SyndromeJournal of Parenteral and Enteral Nutrition, 1990